Drugs / allogeneic adult mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05934825 | Oct 2022 → Oct 2025 | hidradenitis suppurativa | Andalusian Network for Design and Translation of Advanced Therapies | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | allogeneic adult mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05934825 ↗ |
| Route | Other | “Patients will receive an injectable suspension of allogeneic adult mesenchymal stem cells from adipose tissue intralesionally.” NCT05934825 ↗ |